Evidence map›Paper›PMID 34750386›Full record

ArticleNature communications2021

MMAB promotes negative feedback control of cholesterol homeostasis.

Leigh Goedeke, Alberto Canfrán-Duque, Noemi Rotllan, Balkrishna Chaube, Bonne M Thompson, Richard G Lee, Gary W Cline, Jeffrey G McDonald, Gerald I Shulman, Miguel A Lasunción and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. The role of BCancer & metabolism · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Leigh GoedekeVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT, USA.
Alberto Canfrán-DuqueVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-1436-699X
Noemi RotllanVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT, USA.
Balkrishna ChaubeVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0003-4378-7416
Bonne M ThompsonCenter for Human Nutrition, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Richard G LeeCardiovascular Group, Antisense Drug Discovery, Ionis Pharmaceuticals, Carlsbad, CA, 92010, USA.ORCID 0000-0003-1738-1746
Gary W ClineDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Jeffrey G McDonaldCenter for Human Nutrition, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.ORCID 0000-0003-1570-4142
Gerald I ShulmanDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0003-1529-5668
Miguel A LasunciónServicio de Bioquímica-Investigación, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRyCIS) and CIBER de Fisiopatología de la Obesidad y Nutrición (CIBERobn), Madrid, Spain.
Yajaira SuárezVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT, USA.
Carlos Fernández-HernandoVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT, USA. carlos.fernandez@yale.edu.ORCID 0000-0002-3950-1924
Yale University · USThe University of Texas Southwestern Medical Center · USCentro de Investigación Biomédica en Red · ESIonis Pharmaceuticals (United States) · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI Richard A Flavell · 1993 to 2026
$44.0M
Novel insights into the molecular and cellular mechanism regulating lipid metabolism and atherosclerosisR35HL135820 · NHLBI · YALE UNIVERSITY · PI FERNANDEZ HERNANDO, CARLOS · 2017 to 2023
$6.0M
microRNAs in vascular diseasesR01HL105945 · NHLBI · YALE UNIVERSITY · PI SUAREZ, YAJAIRA · 2011 to 2020
$3.7M
Development of Controlled Release Mitochondrial Protonophore (CRMP) as a Novel Treatment for Type-2 Diabetes and Non-Alcoholic Steatohepatitis in Dysmetabolic Non-Human PrimatesR01DK119968 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 2019 to 2024
$2.7M
HL-Regulation of Angiogenesis in the Obese Adipose Tissue by Secreted microRNAsR01HL135012 · NHLBI · YALE UNIVERSITY · PI SUAREZ, YAJAIRA · 2017 to 2020
$2.1M
Glucagon Regulation of Hepatic Mitochondrial Activity and Glucose Metabolism by InsP3R-1R01DK116774 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 2018 to 2021
$1.7M
Cellular and molecular mechanisms of diabetic atherosclerosisK99HL150234 · NHLBI · YALE UNIVERSITY · PI GOEDEKE, LEIGH · 2020 to 2021
$214k
NCATS NIH HHS UL1 TR001863NCI NIH HHS P30 CA016087NHLBI NIH HHS K99 HL150234NHLBI NIH HHS R01 HL105945NHLBI NIH HHS R01 HL135012NHLBI NIH HHS R35 HL135820NIDDK NIH HHS P30 DK045735NIDDK NIH HHS R01 DK116774NIDDK NIH HHS R01 DK119968
6 · The paper itself

Abstract

Intricate regulatory networks govern the net balance of cholesterol biosynthesis, uptake and efflux; however, the mechanisms surrounding cholesterol homeostasis remain incompletely understood. Here, we develop an integrative genomic strategy to detect regulators of LDLR activity and identify 250 genes whose knockdown affects LDL-cholesterol uptake and whose expression is modulated by intracellular cholesterol levels in human hepatic cells. From these hits, we focus on MMAB, an enzyme which catalyzes the conversion of vitamin B

Indexed as

Feedback, PhysiologicalHomeostasisAlkyl and Aryl TransferasesAnimalsCell Line, TumorCholesterolCholesterol, LDLGene Expression ProfilingHeLa CellsHep G2 CellsHumansHydroxymethylglutaryl CoA ReductasesLiverMiceMice, Inbred C57BLMice, KnockoutAlkyl and Aryl TransferasesCholesterolCholesterol, LDLHMGCR protein, humanHydroxymethylglutaryl CoA ReductasesMMAB protein, humanReceptors, LDLSterol Regulatory Element Binding Protein 2

Identifiers

PMID34750386
PMCPMC8575900
OpenAlexW3213996926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.